Open prospective trial an 6-thioguanine for chronic active Crohn's disease

被引：0
|
作者：
Herrlinger, KR
Kreisel, W
Schwab, M
Fischer, C
Schölmerich, J
Fleig, WE
Rühl, A
Reinshagen, M
Metzler, J
Fellermann, K
Stange, EF
机构：
来源：
GASTROENTEROLOGY | 2002年 / 122卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
T1203
引用
收藏
页码：A432 / A432
页数：1
相关论文
共 50 条
  • [21] Low 6-thioguanine nucleotide level: Effective in maintaining remission in Chinese patients with Crohn's disease
    Feng, Rui
    Guo, Jing
    Zhang, Sheng-hong
    Qiu, Yun
    Chen, Bai-li
    He, Yao
    Zeng, Zhi-rong
    Ben-Horin, Shomron
    Chen, Min-hu
    Mao, Ren
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2019, 34 (04) : 679 - 685
  • [22] Biotransformation of 6-thioguanine in inflammatory bowel disease patients: a comparison of oral and intravenous administration of 6-thioguanine
    Jharap, B.
    de Boer, N. K. H.
    Vos, R. M.
    Smid, K.
    Zwiers, A.
    Peters, G. J.
    Mulder, C. J. J.
    Wilhelm, A. J.
    van Bodegraven, A. A.
    BRITISH JOURNAL OF PHARMACOLOGY, 2011, 163 (04) : 722 - 731
  • [23] An open trial of pentoxifylline for active Crohn's disease.
    Katz, J
    Geraci, K
    GASTROENTEROLOGY, 1997, 112 (04) : A1009 - A1009
  • [24] Safe 6-thioguanine therapy of a TPMT deficient Crohn's disease patient by using therapeutic drug monitoring
    Mares, W. G. N.
    Wong, D. R.
    Gilissen, L. P. L.
    Masclee, A. A. M.
    Hooymans, P. M.
    Engels, L. G. J. B.
    JOURNAL OF CROHNS & COLITIS, 2009, 3 (02): : 128 - 130
  • [25] Measurements of 6-thioguanine nucleotide levels with TPMT and NUDT15 genotyping in patients with Crohn's disease
    Lee, Ji Hyeon
    Kim, Tae Jun
    Kim, Eun Ran
    Hong, Sung Noh
    Chang, Dong Kyung
    Choi, Li-Hwa
    Woo, Hye In
    Lee, Soo-Youn
    Kim, Young-Ho
    PLOS ONE, 2017, 12 (12):
  • [26] AZATHIOPRINE AND 6-THIOGUANINE BUT NOT 6-MERCAPTOPURINE INHIBIT INTRA-MACROPHAGE REPLICATION OF CROHN'S DISEASE ESCHERICHIA COLI
    Knight, P.
    Campbell, B. J.
    Rhodes, J. M.
    GUT, 2011, 60
  • [27] 6-thioguanine induced apoptosis: a putative immunosuppressive mechanism of action for 6-mercaptopurine in patients with Crohn's disease.
    Carvalho, RS
    Mahoney, JA
    Hines, D
    Cuffari, C
    GASTROENTEROLOGY, 2005, 128 (04) : A12 - A12
  • [28] Chronic liver disease related to 6-thioguanine in children with acute lymphoblastic leukaemia
    De Bruyne, R
    Portmann, B
    Samyn, M
    Bansal, S
    Knisely, A
    Mieli-Vergani, G
    Dhawan, A
    JOURNAL OF HEPATOLOGY, 2006, 44 (02) : 407 - 410
  • [29] 6-thioguanine is well tolerated and reasonably effective in Crohn's disease patients who are resistant or intolerant of azathioprine and methotrexate
    Soon, SY
    Ansari, A
    Fong, FM
    Hirst, J
    Sanderson, JD
    GUT, 2004, 53 : A104 - A104
  • [30] Open label trial of oral clarithromycin in active Crohn's disease
    Leiper, K
    Morris, AI
    Rhodes, JM
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2000, 14 (06) : 801 - 806
12345